AFP8 天
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance ...
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary ...
Medscape6 天
CAR T-Cell Therapy Safe in Those With Autoimmune Disease
CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...
Multiple Sclerosis News Today1 天
TG Therapeutics advancing CAR T-cell therapy toward Phase 1 trial
TG Therapeutics will use MaxCyte’s technology to advance toward a clinical trial its azer-cel CAR T-cell therapy for ...
The New England Journal of Medicine7 天
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
In the absence of direct evidence, the contribution of insertional mutagenesis to the development of T-cell lymphoma is currently unclear. (Funded by Johnson & Johnson and Legend Biotech USA ...
technologynetworks21 天
AI Tool Predicts T-Cell Epitopes for Accelerated Vaccine Development
An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...
Mouse study finds impaired cell development: Intermittent fasting could be unsafe for teenagers
A recent study reveals that age plays a significant role in the outcomes of intermittent fasting. Researchers from Technical ...